We aimed to characterize changes in binding of (-)-[ 
F]
Flubatine throughout the brain was quantified as change in (-)-[ 
| I N TR ODU C TI ON
In vivo imaging of a 4 b 2 -containing nicotinic acetylcholine receptors (a 4 b 2 *-nAChRs) with positron emission tomography (PET) has important clinical applications for studying addiction and other neuropsychiatric disorders (Cosgrove et al., 2009; Esterlis et al., 2014; Hannestad et al., 2013; Saricicek et al., 2012) . (-)-[ 18 F]Flubatine is an effective PET tracer for in vivo imaging of a 4 b 2 *-nAChRs in nonhuman primates (Bois et al., 2015) and was shown to have favorable kinetic properties in humans (Sabri et al., 2015) .
Previous PET studies quantified (-)-[
18 F]Flubatine binding with distribution volume (V T ), using the gold standard of measuring radiotracer concentrations in arterial plasma for kinetic modeling analysis. Reference tissue modeling approaches eliminate the need for invasive arterial sampling, simplifying logistical and analytic aspects of outcome parameter estimation. An ideal reference region contains negligible amounts of specifically bound radiotracer, and is used as a proxy of nondisplaceable radiotracer kinetics in target regions. A previous study of nicotine occupancy in nonhuman primates with (-)-[ 18 F]Flubatine observed that V T in cerebellum, a potential reference region, was greater than nondisplaceable volume of distribution (V ND ), suggesting specific binding in cerebellum (Bois et al., 2015 (Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991) . A physical examination, routine blood tests, medical and psychiatric histories, drug screen (urine), ECG, and a pregnancy test (for female participants) were performed as part of the subject screening and were found to be normal or not clinically significant to continue. Screening was completed using the Structured Clinical Interview for the DSM-IV to rule out Axis I disorders other than nicotine dependence. Exclusion criteria also included prescription or illegal psychotropic medication use within the past year and >21 alcoholic drinks per week for women and 35 drinks per week for men. Subjects were instructed to abstain from cigarettes and any form of nicotine, for example, nicotine replacement therapy, e-cigarettes, for 5 consecutive days before their scan. Abstinence was confirmed with CO levels <10 ppm and urine cotinine levels of <100 ng/mL on all 5 days prior to scan and on scan day.
| Imaging
Structural magnetic resonance imaging (MRI) was performed on a 3-T Trio system (Siemens, Erlangen, Germany) for purposes of excluding individuals with brain abnormalities, anatomically co-registering with PET images, and delineation of regions of interest. (-)-[ 18 F]Flubatine was prepared as previously described (Bois et al., 2015) .
(-)-[
18 F]Flubatine (199.6 6 74.5 MBq; 0.38 6 0.26 mg/kg) was injected as a bolus plus constant infusion (B/I) for 210 min with K Bol 5 360 min. A 6-min transmission scan was acquired for attenuation correction after the PET scan. PET data were acquired in list mode with a high-resolution research tomograph (HRRT; Siemens/CTI) started 90 min after the beginning of radiotracer administration, the time when tissue radiotracer levels reach equilibrium (Hillmer et al., 2016) , and continued for an additional 120 min. Subjects smoked a cigarette of their preferred brand starting at 125 min after radiotracer injection, taking 1 puff every 30 s for 5 min while in the scanner, following a previously described paradigm (Morris et al., 2013) . Arterial blood samples were acquired to measure the parent input function as previously described (Hillmer et al., 2016) . Briefly, discrete blood samples were drawn from the radial artery at 90, 105, 120, 135, 150, 165, 180, 195 , and 210 min following radiotracer injection. Plasma was extracted following centrifugation and assayed for radioactivity. The parent fraction was determined by column-switching high-performance liquid chromatography (Hilton et al., 2000) of discrete arterial samples at 90, 120, 180, and 210 and fit with an inverted gamma function. The parent (-)-[ 18 F]Flubatine input function was calculated as the product of radioactivity concentration in plasma and parent fraction of radiotracer in plasma. The plasma-free fraction was also measured in arterial blood samples taken immediately before radiotracer injection.
PET data were reconstructed with ordered-subsets expectation maximization-based MOLAR algorithm correcting for motion on the event level (Polaris Vicra Tracking System, Northern Digital) and for scatter, attenuation, dead-time, normalization, scanner geometry, and point-spread function (Carson et al., 2003) . Emission data were binned into 5-min frames. PET images were aligned to the subject's MRI and then to a standard MRI template. Regional TACs were computed using the AAL atlas (Tzourio-Mazoyer et al., 2002) . Regions defined included the cerebellum (83.9 mm
| Analysis
The outcome measure of (-)-[
18 F]Flubatine V T was estimated in target regions with V T defined as the ratio at equilibrium of total radioactivity concentration in tissue to parent radiotracer in arterial plasma (Innis et al., 2007) . Previous studies have shown that bolus plus constant infusion of
18 F]Flubatine (K Bol 5 360 min) achieved equilibrium in most gray matter regions of interest by 90 min (Hillmer et al., 2016) motivating the use of the equilibrium analysis method here. Quality of equilibrium was evaluated as percent increase in tissue activity of (-)-[
18 F]Flubatine per hour. Tissue concentrations were calculated as the average of activities from two 5-min frames before and after each arterial sample time point (Carson et al., 1997) . V T baseline was measured as an average from 90 to 120 min and V T postcigarette was measured as an average from 180 to 210 min.
Displacement was estimated as the percent difference in V T from baseline to after cigarette smoking. Occupancy by nicotine and nondisplaceable binding (V ND ) were estimated from Lassen plots (Cunningham et al., 2010) including all identified gray matter regions.
To estimate the bias associated with a reference region approach, we calculated the percent difference in BP ND resulting from two different V ND estimates. BP ND was calculated across gray matter regions as (V T baseline 2 V ND )/V ND , first with V ND estimated from a Lassen plot and second with V ND estimated as V T baseline in corpus callosum as a putative reference region.
| R E SU LTS
Equilibrium quality was good; average percent increase per hour (6SD) in radioactivity across subjects was 3.8% 6 2.6% in gray matter and 1.0% 6
11.5% in metabolite-corrected plasma assessed at 90-120 min. Percent increase per hour in corpus callosum was 13.5% 6 10.2% at 90-120 min.
The quality of the new equilibrium achieved after cigarette challenge from 180 to 210 min was also assessed. Percent increase per hour (6SD) in activity at 180-210 min was 3.6% 6 3.4% averaged across gray matter regions, suggesting that a new equilibrium was established at this time after cigarette smoking, and 5.4% 6 15.4% in corpus callosum. Percent increase per hour in metabolite-corrected radiotracer concentration at 180-210 min as an average (6SD) across subjects was 6.7% 6 9.2%.
Time-activity curves of corpus callosum and cerebellum from a representative subject (Figure 1b at 180-210 min (Table 1) . Percent reduction from V T baseline to V T post-cigarette was 21.4% 6 9.3% in corpus callosum, 17.3% 6 8.7% in frontal cortex, 36.1% 6 11.1% in cerebellum, and 22.3% 6 10.1% in putamen across three subjects (Figure 1c ).
V ND and occupancy were calculated for each subject as the x-intercept and slope, respectively, of the Lassen plot (Cunningham et al., 2010) (Supporting Information, Figure 1 ). V T baseline of corpus callosum (6.7 6 1.1 mL/cm 3 ) was not significantly different from the average V ND of 6.9 6 0.9 mL/cm 3 across subjects. Occupancy ranged from 55.2% to 93.7% across the three subjects.
BP ND values estimated using V T from corpus callosum were lower in Subjects 1 and 2 and greater in Subject 3 than BP ND values estimated using V ND from Lassen plots, with percent underestimation ranging from 210.5% in cerebellum to 245.7% in temporal cortex between Subjects 1 and 2 (Supporting Information, Table 1 ).
| D I SCUSSION
In this study, we evaluated the extent of specific (-)-[ The average (6SD) decrease of 36.1% 6 11.1% in cerebellum V T is consistent with observed differences in cerebellum specific binding across species from previous studies using other a 4 b 2 *-nAChR radiotracers (Chefer et al., 2003; Lotfipour, Mandelkern, Alvarez-Estrada, & Brody, 2012; Mukhin et al., 2008) .
Reference region approaches for estimating binding potential rely on the following equation:
and implicitly assume that the distribution volume in the reference region is representative of nondisplaceable radiotracer (i.e., V T(ref) V ND ). If this assumption is not met, then the biased estimation of BP ND becomes 
and the estimated value of BP ND will be less than the true value since V T(ref) > V ND . Moreover, if the specific binding distribution volume in an imperfect reference region (V S(ref) ) is affected differently between the population groups or states studied, this will bias subsequent statistical analyses. Here, the 21.4% 6 9.3% decrease in (-)-[
18 F]Flubatine V T following cigarette challenge in corpus callosum suggest that analysis approaches using this region as a reference is subject to these effects. Indeed, we estimate that quantification of (-)-[
18 F]Flubatine BP ND using corpus callosum as a reference region produced an underestimation of 36.6% 6 6.8% in Subject 1 and 15.0% 6 3.6% in Subject 2.
A further assumption of reference region estimation of BP ND is that values of V ND are comparable between the reference and target regions (i.e., V ND(ref) 5 V ND(ROI) ). However, it is possible that differences in vascularization or tissue composition affect the regional ratios of transfer of parent radiotracer in plasma to and from the non-displaceable compartment (i.e., K 1 /k 2 ), particularly in white versus gray matter. The observation that corpus callosum was not characterized by the same linear occupancy relationship as other regions, that is, these points did not stay on the occupancy line (Supporting Information, Figure 1) The definition of white matter regions is another important consideration for this work. Although we used corpus callosum as the primary white matter region, we conducted an exploratory analysis in the region of centrum semiovale, which yielded an average decrease of (-)-[ These findings corroborate growing evidence to suggest measureable amounts of a 4 b 2 *-nAChRs in white matter, which may even serve a functional role. Studies in mice provide evidence for the presence of a 4 b 2 *-nAChRs on myelinated axons of thalamocortical tracts with the observed function of increasing the axonal excitability of auditory thalamocortical projections in response to endogenous acetylcholine (Kawai, Lazar, & Metherate, 2007) . In addition, Mukhin et al. (2008) (2-FA) across regions in smokers relative to nonsmokers, suggesting upregulation of a 4 b 2 *-nAChRs in smokers, with the greatest increase in a 4 b 2 *-nAChR availability being observed in corpus callosum. Our observation that corpus callosum V T postcigarette was lower than V ND in gray matter regions is consistent with previous work. Brody et al. (2006) suggested that postcigarette levels of 2-FA radioactivity in target regions were higher than postcigarette levels in corpus callosum. Additionally, specific binding to a 4 b 2 *-nAChRs in corpus callosum was estimated as 30% of 2-FA total distribution volume in a paradigm using a combination of low-dose varenicline and smoking to satiety to occupy 2-FA binding sites (Lotfipour et al., 2012) .
In conclusion, this study demonstrates the need for careful characterization of specific binding and nondisplaceable kinetics in a putative reference region. Our observation of displaceable (-)-[ Flubatine-specific binding.
